[AKRX] Akorn, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 21.71 Change: 0.63 (2.99%)
Ext. hours: Change: 0 (0%)

chart AKRX

Refresh chart

Strongest Trends Summary For AKRX

AKRX is in the long-term down -89% below S&P in 2 years and up 276% in 23 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various areas, including ophthalmology, antidotes, anti-infectives, pain management, anesthesia, vaccines, and others. The company operates in three segments: Ophthalmic, Hospital Drugs & Injectables, and Contract Services. The Ophthalmic segment markets diagnostic products, such as mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes, and others for use in the office setting; therapeutic products, including antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers; non-pharmaceutical products comprising artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers; and over-the-counter dry eye and

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS1.68 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 151.41% Sales Growth - Q/Q71.65% P/E19.93
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA1.85% ROE9.14% ROI
Current Ratio3.68 Quick Ratio2.71 Long Term Debt/Equity3.1 Debt Ratio0.35
Gross Margin50.18% Operating Margin16.31% Net Profit Margin5.96% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities972.31 M Cash From Investing Activities-966.54 M Cash From Operating Activities30.92 M Gross Profit128.38 M
Net Profit34.23 M Operating Profit71.91 M Total Assets1.91 B Total Current Assets494.33 M
Total Current Liabilities134.16 M Total Debt1.12 B Total Liabilities1.52 B Total Revenue227.83 M
Technical Data
High 52 week33.56 Low 52 week3.33 Last close3.64 Last change-5.94%
RSI48.76 Average true range0.32 Beta0.93 Volume2.35 M
Simple moving average 20 days-0.15% Simple moving average 50 days-30.37% Simple moving average 200 days-72.33%
Performance Data
Performance Week4.6% Performance Month-17.65% Performance Quart-41.85% Performance Half-74.07%
Performance Year-89.13% Performance Year-to-date7.37% Volatility daily5.48% Volatility weekly12.26%
Volatility monthly25.12% Volatility yearly87.01% Relative Volume219.78% Average Volume3.71 M
New High New Low

News

2019-04-19 18:00:00 | 3-Day Deadline Notice: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-19 17:36:17 | Block & Leviton LLP Reminds Shareholders of Important Deadlines: AKRX, SYNH, INGN, BPI

2019-04-18 17:00:00 | Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5%

2019-04-18 16:05:00 | Akorn Receives FDA Approval for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray OTC

2019-04-18 13:47:30 | APRIL 22 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

2019-04-18 13:40:00 | 4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-18 11:51:56 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

2019-04-18 10:57:00 | AKRX, HIIQ & AMRN - Class Action Deadline Bronstein, Gewirtz & Grossman, LLC

2019-04-17 20:41:10 | Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.

2019-04-16 16:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

2019-04-16 10:57:00 | AKRX, HIIQ & AMRN - Class Action Notice Bronstein, Gewirtz & Grossman, LLC

2019-04-15 17:31:58 | AKORN APRIL 22nd DEADLINE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important Deadline in Securities Class Action Lawsuit Filed by the Firm – AKRX

2019-04-15 13:56:35 | Akorn to Report First Quarter 2019 Financial Results and Host Conference Call

2019-04-15 10:20:26 | Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL

2019-04-15 08:45:12 | Options Traders Expect Huge Moves in Akorn AKRX Stock

2019-04-12 15:30:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-04-12 15:00:00 | AKRX, HIIQ & AMRN - Class Action Reminder Bronstein, Gewirtz & Grossman, LLC

2019-04-12 09:55:00 | AKRX, HIIQ & AMRN - Class Action Update Bronstein, Gewirtz & Grossman, LLC

2019-04-11 15:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

2019-04-10 22:21:15 | AKRX ALERT: Zhang Investor Law Reminds Investors of April 22 Deadline in Securities Class Action Lawsuit Against Akorn, Inc. – AKRX

2019-04-09 20:31:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX

2019-04-09 10:48:00 | Class Action Reminder - AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

2019-04-09 10:46:47 | See what the IHS Markit Score report has to say about Akorn Inc.

2019-04-08 17:27:00 | INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In AKRX, UMC, CAG or CNDT To Contact The Firm

2019-04-08 15:05:00 | APRIL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-04-08 14:05:00 | SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. - AKRX

2019-04-07 09:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

2019-04-05 15:00:00 | Class Action Reminder – AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

2019-04-05 10:46:00 | Class Action Update - AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

2019-04-04 15:35:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

2019-04-04 10:45:00 | Bronstein, Gewirtz & Grossman, LLC Class Action - AKRX, HIIQ & AMRN

2019-04-03 19:04:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-04-03 00:00:46 | Some drug companies are still imposing triple-digit price rises

2019-04-02 17:34:08 | AKORN CLASS ACTION NOTICE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important April 22nd Deadline in Securities Class Action Lawsuit Filed by the Firm – AKRX

2019-04-02 17:25:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-04-02 15:55:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline– AKRX

2019-04-02 15:24:21 | Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL

2019-04-01 11:35:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-03-29 20:15:00 | IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-03-29 16:33:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-03-29 13:54:00 | Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.

2019-03-29 10:42:00 | Class Action Notice – AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

2019-03-28 20:27:00 | Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc. AKRX

2019-03-28 16:12:40 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-03-28 14:27:43 | SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline – AKRX

2019-03-28 10:41:00 | Class Action Update – AKRX, HIIQ & AMRN Bronstein, Gewirtz & Grossman, LLC

2019-03-27 17:15:00 | Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Akorn, Inc. Investors

2019-03-27 16:39:00 | LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm

2019-03-26 18:30:00 | INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akorn, Inc. Investors AKRX

2019-03-26 17:25:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline– AKRX